Diane Prager

Efficacy of Gefitinib, an Inhibitor of the Epidermal Growth Factor Receptor Tyrosine Kinase, in Symptomatic Patients With Non–Small Cell Lung Cancer

Mark G. Kris, Ronald B. Natale, Roy S. Herbst et al. · JAMA · 2003 · 2.5K citations

TRIBUTE: A Phase III Trial of Erlotinib Hydrochloride (OSI-774) Combined With Carboplatin and Paclitaxel Chemotherapy in Advanced Non–Small-Cell Lung Cancer

Roy S. Herbst, Diane Prager, Róbert Hermann et al. · Journal of Clinical Oncology · 2005 · 1.5K citations · Full text

Randomized, Placebo-Controlled Phase II Study of Vandetanib Plus Docetaxel in Previously Treated Non–Small-Cell Lung Cancer

John V. Heymach, Bruce E. Johnson, Diane Prager et al. · Journal of Clinical Oncology · 2007 · 292 citations

Frequent loss of heterozygosity at the retinoblastoma susceptibility gene (RB) locus in aggressive pituitary tumors: evidence for a chromosome 13 tumor suppressor gene other than RB.

Lin Pei, B. Scheithauer, Kálmán Kovács et al. · PubMed · 1995 · 213 citations

Tumor Biology, Rb Sequence Polymorphism, Pituitary Gland +15

Dominant negative inhibition of tumorigenesis in vivo by human insulin-like growth factor I receptor mutant.

Diane Prager, H L Li · Proceedings of the National Academy of Sciences · 1994 · 194 citations · Full text

Human Growth, Immunology, Immunoediting +19